Sequential assessments of KRAS-mutated circulating tumor DNA in longitudinal monitoring enable the prediction of prognosis and therapeutic responses in patients with pancreatic cancer.

被引：1
|
作者：
Watanabe, Fumiaki
Suzuki, Koichi
Tamaki, Sawako
Ishikawa, Hideki
Kakizawa, Nao
Noda, Hiroshi
Rikiyama, Toshiki
机构：
[1] Jichi Med Univ, Saitama, Japan
[2] Jichi Med Univ, Saitama Med Ctr, Saitama, Japan
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2019年 / 37卷 / 15期
关键词：
D O I：
10.1200/JCO.2019.37.15_suppl.e15712
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e15712
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Circulating tumor cells (CTC) and KRAS mutant circulating free DNA (cfDNA) detection in peripheral blood as biomarkers in patients diagnosed with exocrine pancreatic cancer
    Julie Earl
    Sandra Garcia-Nieto
    Jose Carlos Martinez-Avila
    José Montans
    Alfonso Sanjuanbenito
    Mercedes Rodríguez-Garrote
    Eduardo Lisa
    Elena Mendía
    Eduardo Lobo
    Núria Malats
    Alfredo Carrato
    Carmen Guillen-Ponce
    BMC Cancer, 15
  • [42] KRAS mutant circulating free DNA (cfDNA) and circulating tumor cell (CTC) detection in peripheral blood as biomarkers in patients diagnosed with exocrine pancreatic cancer
    Earl, J.
    Garcia-Nieto, S.
    Martinez-Avila, C.
    Montans, J.
    Sanjuanbenito, A.
    Rodriguez-Garrote, M.
    Lisa, E.
    Mendia, E.
    Lobo, E.
    Malats, N.
    Carrato, A.
    Guillen, C.
    EUROPEAN JOURNAL OF CANCER, 2015, 51 : S87 - S87
  • [43] Short-term serial circulating tumor DNA assessment predicts therapeutic efficacy for patients with advanced pancreatic cancer
    Hideki Motobayashi
    Yuji Kitahata
    Ken-ichi Okada
    Motoki Miyazawa
    Masaki Ueno
    Shinya Hayami
    Atsushi Miyamoto
    Atsushi Shimizu
    Masatoshi Sato
    Tomohiro Yoshimura
    Yuki Nakamura
    Norio Takemoto
    Tomoki Nakai
    Takahiko Hyo
    Kyohei Matsumoto
    Hiroki Yamaue
    Manabu Kawai
    Journal of Cancer Research and Clinical Oncology, 150
  • [44] Short-term serial circulating tumor DNA assessment predicts therapeutic efficacy for patients with advanced pancreatic cancer
    Motobayashi, Hideki
    Kitahata, Yuji
    Okada, Ken-ichi
    Miyazawa, Motoki
    Ueno, Masaki
    Hayami, Shinya
    Miyamoto, Atsushi
    Shimizu, Atsushi
    Sato, Masatoshi
    Yoshimura, Tomohiro
    Nakamura, Yuki
    Takemoto, Norio
    Nakai, Tomoki
    Hyo, Takahiko
    Matsumoto, Kyohei
    Yamaue, Hiroki
    Kawai, Manabu
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2024, 150 (02)
  • [45] Circulating Tumor DNA in Prediction of Prognosis and Response to Nab-paclitaxel Based First-line Chemotherapy in Metastatic Pancreatic Cancer
    Guan, S.
    Han, Q.
    Li, J.
    Lv, Y.
    Yan, H.
    Han, L.
    Chen, Y.
    Qian, N.
    Wang, Z.
    Shi, H.
    Shi, Y.
    Dai, G.
    PANCREAS, 2019, 48 (10) : 1435 - 1435
  • [46] Circulating tumor DNA methylation profiles enable early diagnosis, prognosis prediction, and screening for colorectal cancer (vol 12, eaax7533, 2020)
    Luo, H.
    Zhao, Q.
    Wei, W.
    Zheng, L.
    Yi, S.
    Li, G.
    Wang, W.
    Sheng, H.
    Pu, H.
    Mo, H.
    Zuo, Z.
    Liu, Z.
    Li, C.
    Xie, C.
    Zeng, Z.
    Li, W.
    Hao, X.
    Liu, Y.
    Cao, S.
    Liu, W.
    Gibson, S.
    Zhang, K.
    Xu, G.
    Xu, R. -H.
    SCIENCE TRANSLATIONAL MEDICINE, 2020, 12 (540)
  • [47] Dynamic assessment of circulating tumor DNA in prediction of response to nab-paclitaxel-based first-line chemotherapy in metastatic pancreatic cancer.
    Shi, Yan
    Guan, Shasha
    Han, Quanli
    Li, Jie
    Lv, Yao
    Yan, Huan
    Dai, Guanghai
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [48] Early evaluation of circulating tumor DNA as marker of therapeutic efficacy and prognosis in breast cancer patients during primary systemic therapy
    Wang, Ru
    Wang, Bin
    Zhang, Huimin
    Liao, Xiaoqin
    Shi, Bohui
    Zhou, Yuhui
    Zhou, Can
    Yan, Yu
    Zhang, Wei
    Wang, Ke
    Ge, Guanqun
    Ren, Yu
    Tang, Xiaojiang
    Gan, Baoyu
    He, Jianjun
    Niu, Ligang
    BREAST, 2024, 76
  • [49] Monitoring therapy response and assessing prognosis by untargeted FAST-SeqS of circulating tumor DNA in metastatic breast cancer patients
    Dandachi, N.
    Suppan, C.
    Brcic, L.
    Tiran, V
    Mueller, D. H.
    Posch, F.
    Ulz, P.
    Heitzer, E.
    Balic, M.
    ONCOLOGY RESEARCH AND TREATMENT, 2019, 42 : 41 - 41
  • [50] Circulating tumor DNA analysis for prediction of prognosis and molecular insights in patients with resectable gastric cancer: results from a prospective study
    Liu, Zheng
    Shi, Zhongyi
    Jiang, Wenchao
    Shen, Zhenbin
    Chen, Weidong
    Shen, Kuntang
    Sun, Yihong
    Tang, Zhaoqing
    Wang, Xuefei
    MEDCOMM, 2025, 6 (02):
12345